Strength, Recovery & Bones
BPC-157: The "Healing Peptide" Everyone's Talking About
What the research on BPC-157 does and doesn't show so far.
If you've been anywhere near the wellness world lately, you've heard the buzz. Your trainer mentioned it. Your friend with the cranky shoulder asked if you'd heard of it. And this summer it even made the evening news.
BPC-157 has become one of the most talked-about peptides out there, and the research behind it is genuinely fascinating. So let's look at what scientists have actually found, what they're still studying, and why so many researchers are excited about it.
So what is BPC-157?
BPC stands for "Body Protection Compound." It's a small peptide, a short chain of just 15 amino acids. Scientists first made it from a protective protein found in human stomach juice.
That origin story is part of why researchers got so curious. Your stomach lining takes a beating every day from acid and digestion, and it's remarkably good at protecting and repairing itself. Researchers wanted to know whether a piece of that protective protein could help other tissues repair, too.
The version you hear about today is made in a lab, and it's much more stable than most peptides. That stability is one reason it's been so widely studied.
What it's being studied for
This is where things get exciting. BPC-157 has been studied for more than 30 years. Most of that work happened in the lab and in animals, and the results have been remarkably consistent.
A 2025 systematic review in orthopedic sports medicine looked at 36 studies published between 1993 and 2024. The researchers concluded that BPC-157 "shows promise for promoting recovery from musculoskeletal injuries." Here are the main areas scientists are exploring:
-
Tendons and ligaments. In animal studies, BPC-157 has been linked to faster, stronger healing of injured tendons and ligaments. Those are the slow-to-heal tissues behind so many nagging aches.
-
Muscle. Researchers have studied it for muscle injuries and recovery, with encouraging results in animal models.
-
Bone. Some studies are looking at whether it supports bone healing.
-
The gut. Given where it came from, it's no surprise that BPC-157 has been studied for protecting the stomach and intestinal lining, including in inflammatory bowel conditions.
Why might it work? Researchers think BPC-157 helps the body grow new blood vessels to injured areas, which means more blood flow, oxygen and nutrients delivered right where repair happens. It also appears to affect nitric oxide, a molecule that helps blood vessels relax, and to support fibroblasts, the cells that build new connective tissue.
The review also noted that the animal studies didn't show harmful effects, which is encouraging for researchers planning future human trials.
Why women over 50 are paying attention
If you read our recovery article, this part will sound familiar. After menopause, a lot of us notice the same frustrating things:
-
Soreness that hangs around for days after a workout
-
Tweaky tendons and joints, or a frozen shoulder that won't let go
-
Little injuries that seem to take forever to heal
-
Joint aches that weren't there five years ago
Part of the reason is that estrogen helped our bodies repair tissue and calm inflammation, and now there's less of it to go around.
That's exactly why the BPC-157 research has caught so many women's attention. The tissues researchers are studying (tendons, ligaments and muscle) are the same ones behind so many of these complaints. And the processes BPC-157 appears to support in the lab, like blood flow to injured areas and building new connective tissue, are the same repair processes that slow down for us after menopause.
To be clear about where the science is: no studies have tested BPC-157 specifically in postmenopausal women yet. So we can't say it will fix any of these problems. But if you've ever wondered why everyone in your Pilates class is talking about it, this overlap is a big part of the reason. It's also why we'd love to see future trials include women our age.
What about studies in people?
This is the part researchers are working on right now. Human studies of BPC-157 are still early and small, but the first results are intriguing:
-
Chronic knee pain. In one study, 7 of 12 people with long-term knee pain reported relief lasting more than six months after a single BPC-157 injection.
-
Ulcerative colitis. An early study with 46 patients tested BPC-157 delivered as an enema, and this is the use the FDA reviewed this year.
-
Safety. A 2025 pilot study gave BPC-157 by IV to two healthy adults and found no safety concerns.
These are small, early studies, the kind researchers run to decide what to test next. The big, carefully controlled trials that would show exactly who it helps, for what and how much haven't been done yet. That's the next chapter.
The big news from 2026
This summer, BPC-157 hit a real milestone. On July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6 to recommend adding BPC-157 to the list of substances licensed compounding pharmacies can use.
Why does that matter? If the FDA accepts the recommendation, a doctor could someday prescribe BPC-157 and have it made by a licensed compounding pharmacy, under real medical oversight and quality standards.
A few things to know about where that stands:
-
It's a recommendation, not a final decision. The FDA still has to review it and go through a formal rulemaking process.
-
It's not FDA approved. Even if BPC-157 is added to the compounding list, it would still be an unapproved drug. Approval would require large clinical trials.
-
It won't happen overnight. Most experts expect any change to take until late 2026 at the earliest, and more likely sometime in 2027.
Still, it's a big signal that BPC-157 is moving from "internet buzz" toward a real, regulated path. That's good news for anyone hoping for safe, quality-controlled access down the road.
The bottom line
BPC-157 is one of the most exciting areas of recovery research right now. Decades of lab and animal studies point to real potential for tendons, ligaments, muscle and the gut. The first human studies are promising, and the FDA advisory vote this summer moves it closer to regulated access.
It's also still being studied. The large human trials that will tell us exactly how well it works, and for whom, are the next step, and we'll be watching closely.
If you're curious about BPC-157 for yourself, the best move is to talk with a doctor who keeps up with peptide research.
Keep reading
- Why Am I Still Sore 3 Days Later? Recovery After 50, Explained
- The $10 Supplement Every Woman Over 50 Should Know About
BPC-157 is not approved by the FDA to diagnose, treat, cure or prevent any disease.